ArticleExpert opinion on drug safety2023

Letter to the editor: consideration on: 'What is the risk of cardiovascular events in osteoporotic patients treated with romosozumab?' by Reid I.R.

Marco Di Monaco et al.PubMed ↗Publisher ↗

No numbers read from the abstract.